CN108265065B - 一种重组黄花蒿1类变应原蛋白及其应用 - Google Patents
一种重组黄花蒿1类变应原蛋白及其应用 Download PDFInfo
- Publication number
- CN108265065B CN108265065B CN201711379683.6A CN201711379683A CN108265065B CN 108265065 B CN108265065 B CN 108265065B CN 201711379683 A CN201711379683 A CN 201711379683A CN 108265065 B CN108265065 B CN 108265065B
- Authority
- CN
- China
- Prior art keywords
- rart
- protein
- gene
- recombinant
- expression
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 78
- 102000004169 proteins and genes Human genes 0.000 title claims abstract description 30
- 235000001405 Artemisia annua Nutrition 0.000 title claims abstract description 20
- 240000000011 Artemisia annua Species 0.000 title claims abstract description 20
- 239000013566 allergen Substances 0.000 title claims description 17
- 230000014509 gene expression Effects 0.000 claims abstract description 32
- 210000004027 cell Anatomy 0.000 claims abstract description 19
- 238000000034 method Methods 0.000 claims abstract description 15
- 239000006228 supernatant Substances 0.000 claims description 13
- 239000013598 vector Substances 0.000 claims description 11
- 238000005277 cation exchange chromatography Methods 0.000 claims description 7
- 210000004978 chinese hamster ovary cell Anatomy 0.000 claims description 4
- 230000003321 amplification Effects 0.000 claims 1
- 238000003199 nucleic acid amplification method Methods 0.000 claims 1
- 210000004962 mammalian cell Anatomy 0.000 abstract description 33
- 235000018102 proteins Nutrition 0.000 abstract description 25
- 238000005457 optimization Methods 0.000 abstract description 18
- 238000000746 purification Methods 0.000 abstract description 16
- 230000000694 effects Effects 0.000 abstract description 7
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 abstract description 3
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 abstract description 3
- 238000011160 research Methods 0.000 abstract description 3
- 108010064851 Plant Proteins Proteins 0.000 abstract description 2
- 206010070834 Sensitisation Diseases 0.000 abstract description 2
- 235000021118 plant-derived protein Nutrition 0.000 abstract description 2
- 230000008313 sensitization Effects 0.000 abstract description 2
- 238000002331 protein detection Methods 0.000 abstract 2
- 238000011161 development Methods 0.000 abstract 1
- 238000012362 drug development process Methods 0.000 abstract 1
- 238000000605 extraction Methods 0.000 abstract 1
- 238000009776 industrial production Methods 0.000 abstract 1
- 244000000010 microbial pathogen Species 0.000 abstract 1
- 231100000614 poison Toxicity 0.000 abstract 1
- 229920001184 polypeptide Polymers 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 238000003908 quality control method Methods 0.000 abstract 1
- 230000001235 sensitizing effect Effects 0.000 abstract 1
- 239000003440 toxic substance Substances 0.000 abstract 1
- 108020004705 Codon Proteins 0.000 description 28
- RXWNCPJZOCPEPQ-NVWDDTSBSA-N puromycin Chemical compound C1=CC(OC)=CC=C1C[C@H](N)C(=O)N[C@H]1[C@@H](O)[C@H](N2C3=NC=NC(=C3N=C2)N(C)C)O[C@@H]1CO RXWNCPJZOCPEPQ-NVWDDTSBSA-N 0.000 description 12
- 239000000243 solution Substances 0.000 description 12
- 241000196324 Embryophyta Species 0.000 description 10
- 239000012228 culture supernatant Substances 0.000 description 10
- 239000012149 elution buffer Substances 0.000 description 10
- 239000000872 buffer Substances 0.000 description 8
- 238000009826 distribution Methods 0.000 description 7
- 238000001502 gel electrophoresis Methods 0.000 description 7
- 239000002773 nucleotide Substances 0.000 description 7
- 125000003729 nucleotide group Chemical group 0.000 description 7
- 239000013612 plasmid Substances 0.000 description 7
- 208000035285 Allergic Seasonal Rhinitis Diseases 0.000 description 6
- 108020004414 DNA Proteins 0.000 description 6
- FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 description 6
- 206010048908 Seasonal allergy Diseases 0.000 description 6
- 238000010828 elution Methods 0.000 description 6
- 239000006167 equilibration buffer Substances 0.000 description 6
- 238000004255 ion exchange chromatography Methods 0.000 description 6
- 229950010131 puromycin Drugs 0.000 description 6
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 6
- 238000004458 analytical method Methods 0.000 description 5
- 244000030166 artemisia Species 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 238000012216 screening Methods 0.000 description 5
- 241000283973 Oryctolagus cuniculus Species 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 4
- 230000004071 biological effect Effects 0.000 description 4
- 239000000287 crude extract Substances 0.000 description 4
- 238000011067 equilibration Methods 0.000 description 4
- 239000013613 expression plasmid Substances 0.000 description 4
- 201000004338 pollen allergy Diseases 0.000 description 4
- 235000003826 Artemisia Nutrition 0.000 description 3
- 235000003261 Artemisia vulgaris Nutrition 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 150000001413 amino acids Chemical group 0.000 description 3
- 235000009052 artemisia Nutrition 0.000 description 3
- 125000002091 cationic group Chemical group 0.000 description 3
- 238000011097 chromatography purification Methods 0.000 description 3
- 238000010276 construction Methods 0.000 description 3
- 238000000586 desensitisation Methods 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 238000005342 ion exchange Methods 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 239000012474 protein marker Substances 0.000 description 3
- 238000001742 protein purification Methods 0.000 description 3
- 230000014616 translation Effects 0.000 description 3
- 241000219318 Amaranthus Species 0.000 description 2
- 206010002198 Anaphylactic reaction Diseases 0.000 description 2
- 235000003932 Betula Nutrition 0.000 description 2
- 241000219429 Betula Species 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 241000218228 Humulus Species 0.000 description 2
- 108091028043 Nucleic acid sequence Proteins 0.000 description 2
- 241000218657 Picea Species 0.000 description 2
- 235000005205 Pinus Nutrition 0.000 description 2
- 241000218602 Pinus <genus> Species 0.000 description 2
- 235000003846 Ricinus Nutrition 0.000 description 2
- 241000322381 Ricinus <louse> Species 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000006978 adaptation Effects 0.000 description 2
- 238000000246 agarose gel electrophoresis Methods 0.000 description 2
- 208000026935 allergic disease Diseases 0.000 description 2
- 230000000172 allergic effect Effects 0.000 description 2
- 208000003455 anaphylaxis Diseases 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- 229910002092 carbon dioxide Inorganic materials 0.000 description 2
- 230000003833 cell viability Effects 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000005520 cutting process Methods 0.000 description 2
- 239000013604 expression vector Substances 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 238000011068 loading method Methods 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 101150111388 pac gene Proteins 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 108010077112 prolyl-proline Proteins 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 238000013519 translation Methods 0.000 description 2
- 230000035899 viability Effects 0.000 description 2
- NBDYVTYCSKWBQI-ATIWLJMLSA-N (2s)-1-[(2s)-1-[(2s)-1-[(2s)-1-[(2s)-2-amino-3-hydroxypropanoyl]pyrrolidine-2-carbonyl]pyrrolidine-2-carbonyl]pyrrolidine-2-carbonyl]pyrrolidine-2-carboxylic acid Chemical compound OC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(=O)N2[C@@H](CCC2)C(=O)N2[C@@H](CCC2)C(O)=O)CCC1 NBDYVTYCSKWBQI-ATIWLJMLSA-N 0.000 description 1
- OJHZNMVJJKMFGX-RNWHKREASA-N (4r,4ar,7ar,12bs)-9-methoxy-3-methyl-1,2,4,4a,5,6,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinoline-7-one;2,3-dihydroxybutanedioic acid Chemical compound OC(=O)C(O)C(O)C(O)=O.O=C([C@@H]1O2)CC[C@H]3[C@]4([H])N(C)CC[C@]13C1=C2C(OC)=CC=C1C4 OJHZNMVJJKMFGX-RNWHKREASA-N 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- GGNHBHYDMUDXQB-KBIXCLLPSA-N Ala-Glu-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)N GGNHBHYDMUDXQB-KBIXCLLPSA-N 0.000 description 1
- VGPWRRFOPXVGOH-BYPYZUCNSA-N Ala-Gly-Gly Chemical compound C[C@H](N)C(=O)NCC(=O)NCC(O)=O VGPWRRFOPXVGOH-BYPYZUCNSA-N 0.000 description 1
- OLVCTPPSXNRGKV-GUBZILKMSA-N Ala-Pro-Pro Chemical compound C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(O)=O)CCC1 OLVCTPPSXNRGKV-GUBZILKMSA-N 0.000 description 1
- QOIGKCBMXUCDQU-KDXUFGMBSA-N Ala-Thr-Pro Chemical compound C[C@H]([C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](C)N)O QOIGKCBMXUCDQU-KDXUFGMBSA-N 0.000 description 1
- JDHOJQJMWBKHDB-CIUDSAMLSA-N Asp-Asn-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CC(=O)O)N JDHOJQJMWBKHDB-CIUDSAMLSA-N 0.000 description 1
- OMMIEVATLAGRCK-BYPYZUCNSA-N Asp-Gly-Gly Chemical compound OC(=O)C[C@H](N)C(=O)NCC(=O)NCC(O)=O OMMIEVATLAGRCK-BYPYZUCNSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000219501 Casuarina Species 0.000 description 1
- 241000218645 Cedrus Species 0.000 description 1
- 241000219312 Chenopodium Species 0.000 description 1
- 244000281762 Chenopodium ambrosioides Species 0.000 description 1
- 235000000509 Chenopodium ambrosioides Nutrition 0.000 description 1
- 235000005490 Chenopodium botrys Nutrition 0.000 description 1
- 108700010070 Codon Usage Proteins 0.000 description 1
- 240000005109 Cryptomeria japonica Species 0.000 description 1
- HAYVLBZZBDCKRA-SRVKXCTJSA-N Cys-His-Lys Chemical compound C1=C(NC=N1)C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CS)N HAYVLBZZBDCKRA-SRVKXCTJSA-N 0.000 description 1
- ZHCCYSDALWJITB-SRVKXCTJSA-N Cys-Phe-Cys Chemical compound N[C@@H](CS)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CS)C(O)=O ZHCCYSDALWJITB-SRVKXCTJSA-N 0.000 description 1
- WZJLBUPPZRZNTO-CIUDSAMLSA-N Cys-Ser-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CS)N WZJLBUPPZRZNTO-CIUDSAMLSA-N 0.000 description 1
- 101150074155 DHFR gene Proteins 0.000 description 1
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
- 102100024746 Dihydrofolate reductase Human genes 0.000 description 1
- 241001212789 Dynamis Species 0.000 description 1
- RUFHOVYUYSNDNY-ACZMJKKPSA-N Glu-Ala-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCC(O)=O RUFHOVYUYSNDNY-ACZMJKKPSA-N 0.000 description 1
- UTKUTMJSWKKHEM-WDSKDSINSA-N Glu-Ala-Gly Chemical compound OC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](N)CCC(O)=O UTKUTMJSWKKHEM-WDSKDSINSA-N 0.000 description 1
- BPCLDCNZBUYGOD-BPUTZDHNSA-N Glu-Trp-Glu Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@H](CCC(O)=O)N)C(=O)N[C@@H](CCC(O)=O)C(O)=O)=CNC2=C1 BPCLDCNZBUYGOD-BPUTZDHNSA-N 0.000 description 1
- PYTZFYUXZZHOAD-WHFBIAKZSA-N Gly-Ala-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)CN PYTZFYUXZZHOAD-WHFBIAKZSA-N 0.000 description 1
- YWAQATDNEKZFFK-BYPYZUCNSA-N Gly-Gly-Ser Chemical compound NCC(=O)NCC(=O)N[C@@H](CO)C(O)=O YWAQATDNEKZFFK-BYPYZUCNSA-N 0.000 description 1
- VLIJYPMATZSOLL-YUMQZZPRSA-N Gly-Lys-Cys Chemical compound C(CCN)C[C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)CN VLIJYPMATZSOLL-YUMQZZPRSA-N 0.000 description 1
- POJJAZJHBGXEGM-YUMQZZPRSA-N Gly-Ser-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)CN POJJAZJHBGXEGM-YUMQZZPRSA-N 0.000 description 1
- ABPRMMYHROQBLY-NKWVEPMBSA-N Gly-Ser-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CO)NC(=O)CN)C(=O)O ABPRMMYHROQBLY-NKWVEPMBSA-N 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- YADRBUZBKHHDAO-XPUUQOCRSA-N His-Gly-Ala Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)NCC(=O)N[C@@H](C)C(O)=O YADRBUZBKHHDAO-XPUUQOCRSA-N 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- QPRQGENIBFLVEB-BJDJZHNGSA-N Leu-Ala-Ile Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O QPRQGENIBFLVEB-BJDJZHNGSA-N 0.000 description 1
- KWURTLAFFDOTEQ-GUBZILKMSA-N Leu-Cys-Glu Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N KWURTLAFFDOTEQ-GUBZILKMSA-N 0.000 description 1
- 102000003960 Ligases Human genes 0.000 description 1
- 108090000364 Ligases Proteins 0.000 description 1
- JCFYLFOCALSNLQ-GUBZILKMSA-N Lys-Ala-Gln Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(O)=O JCFYLFOCALSNLQ-GUBZILKMSA-N 0.000 description 1
- RDIILCRAWOSDOQ-CIUDSAMLSA-N Lys-Cys-Asp Chemical compound C(CCN)C[C@@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(=O)O)C(=O)O)N RDIILCRAWOSDOQ-CIUDSAMLSA-N 0.000 description 1
- SFQPJNQDUUYCLA-BJDJZHNGSA-N Lys-Cys-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H](CCCCN)N SFQPJNQDUUYCLA-BJDJZHNGSA-N 0.000 description 1
- VEGLGAOVLFODGC-GUBZILKMSA-N Lys-Glu-Ser Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(O)=O VEGLGAOVLFODGC-GUBZILKMSA-N 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 241000209466 Platanus Species 0.000 description 1
- APKRGYLBSCWJJP-FXQIFTODSA-N Pro-Ala-Asp Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CC(O)=O)C(O)=O APKRGYLBSCWJJP-FXQIFTODSA-N 0.000 description 1
- KDBHVPXBQADZKY-GUBZILKMSA-N Pro-Pro-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H]1NCCC1 KDBHVPXBQADZKY-GUBZILKMSA-N 0.000 description 1
- LEIKGVHQTKHOLM-IUCAKERBSA-N Pro-Pro-Gly Chemical compound OC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H]1NCCC1 LEIKGVHQTKHOLM-IUCAKERBSA-N 0.000 description 1
- SBVPYBFMIGDIDX-SRVKXCTJSA-N Pro-Pro-Pro Chemical compound OC(=O)[C@@H]1CCCN1C(=O)[C@H]1N(C(=O)[C@H]2NCCC2)CCC1 SBVPYBFMIGDIDX-SRVKXCTJSA-N 0.000 description 1
- POQFNPILEQEODH-FXQIFTODSA-N Pro-Ser-Ala Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(O)=O POQFNPILEQEODH-FXQIFTODSA-N 0.000 description 1
- 206010039085 Rhinitis allergic Diseases 0.000 description 1
- DINQYZRMXGWWTG-GUBZILKMSA-N Ser-Pro-Pro Chemical compound OC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(O)=O)CCC1 DINQYZRMXGWWTG-GUBZILKMSA-N 0.000 description 1
- 241000187747 Streptomyces Species 0.000 description 1
- 244000234181 Syzygium samarangense Species 0.000 description 1
- 235000012096 Syzygium samarangense Nutrition 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- JEDIEMIJYSRUBB-FOHZUACHSA-N Thr-Asp-Gly Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(O)=O JEDIEMIJYSRUBB-FOHZUACHSA-N 0.000 description 1
- IQPWNQRRAJHOKV-KATARQTJSA-N Thr-Ser-Lys Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CCCCN IQPWNQRRAJHOKV-KATARQTJSA-N 0.000 description 1
- IJKNKFJZOJCKRR-GBALPHGKSA-N Thr-Trp-Ser Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@@H](N)[C@H](O)C)C(=O)N[C@@H](CO)C(O)=O)=CNC2=C1 IJKNKFJZOJCKRR-GBALPHGKSA-N 0.000 description 1
- LMKKMCGTDANZTR-BZSNNMDCSA-N Tyr-Phe-Asp Chemical compound C([C@H](N)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC(O)=O)C(O)=O)C1=CC=C(O)C=C1 LMKKMCGTDANZTR-BZSNNMDCSA-N 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 108010076324 alanyl-glycyl-glycine Proteins 0.000 description 1
- 108010024078 alanyl-glycyl-serine Proteins 0.000 description 1
- 108010070944 alanylhistidine Proteins 0.000 description 1
- 108010087924 alanylproline Proteins 0.000 description 1
- 229940074608 allergen extract Drugs 0.000 description 1
- 201000009961 allergic asthma Diseases 0.000 description 1
- 201000010105 allergic rhinitis Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 229940126574 aminoglycoside antibiotic Drugs 0.000 description 1
- 239000002647 aminoglycoside antibiotic agent Substances 0.000 description 1
- 108010047857 aspartylglycine Proteins 0.000 description 1
- 108010092854 aspartyllysine Proteins 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 238000005341 cation exchange Methods 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 230000005859 cell recognition Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 108010069495 cysteinyltyrosine Proteins 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 108020001096 dihydrofolate reductase Proteins 0.000 description 1
- 229910000397 disodium phosphate Inorganic materials 0.000 description 1
- 239000012154 double-distilled water Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000002532 enzyme inhibitor Substances 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000004052 folic acid antagonist Substances 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- VPZXBVLAVMBEQI-UHFFFAOYSA-N glycyl-DL-alpha-alanine Natural products OC(=O)C(C)NC(=O)CN VPZXBVLAVMBEQI-UHFFFAOYSA-N 0.000 description 1
- 108010015792 glycyllysine Proteins 0.000 description 1
- 238000003119 immunoblot Methods 0.000 description 1
- 230000005847 immunogenicity Effects 0.000 description 1
- 238000009169 immunotherapy Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 229930027917 kanamycin Natural products 0.000 description 1
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
- 229960000318 kanamycin Drugs 0.000 description 1
- 229930182823 kanamycin A Natural products 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 108010054155 lysyllysine Proteins 0.000 description 1
- 210000003794 male germ cell Anatomy 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000012452 mother liquor Substances 0.000 description 1
- 238000001668 nucleic acid synthesis Methods 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000007918 pathogenicity Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 108010093296 prolyl-prolyl-alanine Proteins 0.000 description 1
- 108010087846 prolyl-prolyl-glycine Proteins 0.000 description 1
- 108010029020 prolylglycine Proteins 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 239000009342 ragweed pollen Substances 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 230000001932 seasonal effect Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000002864 sequence alignment Methods 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 108010026333 seryl-proline Proteins 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000010473 stable expression Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000004114 suspension culture Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 108010072986 threonyl-seryl-lysine Proteins 0.000 description 1
- 238000012876 topography Methods 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 238000001262 western blot Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/22—Vectors comprising a coding region that has been codon optimised for expression in a respective host
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Botany (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Description
Claims (6)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2016112705252 | 2016-12-31 | ||
CN201611270525 | 2016-12-31 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN108265065A CN108265065A (zh) | 2018-07-10 |
CN108265065B true CN108265065B (zh) | 2021-04-27 |
Family
ID=62772289
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201711379683.6A Active CN108265065B (zh) | 2016-12-31 | 2017-12-20 | 一种重组黄花蒿1类变应原蛋白及其应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108265065B (zh) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116410276A (zh) * | 2021-12-30 | 2023-07-11 | 江苏众红生物工程创药研究院有限公司 | 重组北艾花粉i型变应原及其制备方法和应用 |
CN116410275A (zh) * | 2021-12-30 | 2023-07-11 | 江苏众红生物工程创药研究院有限公司 | 重组黄花蒿花粉i型变应原及其制备方法和应用 |
CN118359690A (zh) * | 2023-01-17 | 2024-07-19 | 江苏众红生物工程创药研究院有限公司 | 重组艾蒿花粉iii型变应原及其制备方法和应用 |
CN118359691A (zh) * | 2023-01-17 | 2024-07-19 | 江苏众红生物工程创药研究院有限公司 | 重组黄花蒿花粉iii型变应原及其制备方法和应用 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2008164523A (ja) * | 2006-12-28 | 2008-07-17 | Nippon Medical Soken:Kk | 唾液を利用したアレルギー診断薬 |
WO2010043675A1 (en) * | 2008-10-15 | 2010-04-22 | Alk-Abelló A/S | Pharmaceutical product for up-dosing of allergy vaccine |
CN102512673A (zh) * | 2011-12-21 | 2012-06-27 | 北京新华联协和药业有限责任公司 | 蒿属花粉变应原注射用疫苗及其制备方法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101905022B (zh) * | 2009-06-08 | 2013-10-30 | 浙江我武生物科技股份有限公司 | 一种稳定的含有蒿属花粉变应原的药物组合物及其制备方法 |
CN102552900A (zh) * | 2011-12-21 | 2012-07-11 | 北京新华联协和药业有限责任公司 | 蒿属花粉变应原疫苗及其制备方法和应用 |
WO2015077434A2 (en) * | 2013-11-20 | 2015-05-28 | La Jolla Institute For Allergy And Immunology | Pan pollen immunogens and methods and uses for immune response modulation |
CN103710368B (zh) * | 2013-12-30 | 2016-08-17 | 江苏众红生物工程创药研究院有限公司 | 哺乳动物细胞表达的人激肽释放酶和编码基因及其应用 |
CN106967696B (zh) * | 2017-02-22 | 2020-01-14 | 杭州艾乐吉生物科技有限公司 | 一种蒿属植物花粉的过敏原及其应用 |
-
2017
- 2017-12-20 CN CN201711379683.6A patent/CN108265065B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2008164523A (ja) * | 2006-12-28 | 2008-07-17 | Nippon Medical Soken:Kk | 唾液を利用したアレルギー診断薬 |
WO2010043675A1 (en) * | 2008-10-15 | 2010-04-22 | Alk-Abelló A/S | Pharmaceutical product for up-dosing of allergy vaccine |
CN102512673A (zh) * | 2011-12-21 | 2012-06-27 | 北京新华联协和药业有限责任公司 | 蒿属花粉变应原注射用疫苗及其制备方法 |
Non-Patent Citations (3)
Title |
---|
Expression of the major mugwort pollen allergen Art v 1 in tobacco plants and cell cultures: problems and perspectives for allergen production in plants;Marc Siegert等;《Plant Cell Rep》;20111213;第31卷;561-571 * |
大籽蒿花粉过敏原的分离、鉴定与纯化;李兴永等;《中国免疫学杂志》;20141231;第30卷(第7期);913-916 * |
新疆黄花蒿花粉变应原的分离及纯化;李志良等;《新疆医学院学报》;19860702;第9卷(第2期);145-151 * |
Also Published As
Publication number | Publication date |
---|---|
CN108265065A (zh) | 2018-07-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN108265065B (zh) | 一种重组黄花蒿1类变应原蛋白及其应用 | |
CN108265056B (zh) | 一种重组户尘螨1类变应原蛋白及其制备方法和应用 | |
US10975128B2 (en) | Recombinant Dermatophagoides farinae type 1 allergen protein and its preparation method and application | |
CN107973841B (zh) | Cho细胞表达的重组牛病毒性腹泻病毒e2蛋白及亚单位疫苗的制备方法和应用 | |
CN108265064B (zh) | 一种重组黄花蒿3类变应原蛋白及其应用 | |
CN111349154A (zh) | 一种重组人促卵泡激素及其制备方法和药物应用 | |
CN108265057B (zh) | 一种重组户尘螨2类变应原蛋白及其制备方法和应用 | |
US11236137B2 (en) | Recombinant Dermatophagoides farinae type 2 allergen protein and its preparation method and application | |
CN103710367B (zh) | 一种重组人激肽释放酶1及其编码基因和制备方法 | |
CN116574700B (zh) | 大麻二酚酸合成酶突变体及其应用 | |
CN112142827B (zh) | 一种猪伪狂犬病毒的gB亚单位重组蛋白及其制备方法和应用 | |
CN111378017B (zh) | 小反刍兽疫病毒的亚单位f蛋白及其制备方法和应用 | |
CN103509100B (zh) | 一种白细胞介素‑1受体拮抗剂突变体 | |
CN109852653B (zh) | 重组尘螨II型变应原Der p2和Der f2蛋白的制备与应用 | |
CN109852652B (zh) | 重组尘螨Ⅰ型变应原Der p1和Der f1蛋白的制备与应用 | |
CN112225781A (zh) | 一种高效表达新型冠状病毒n蛋白的方法 | |
CN115232804B (zh) | 一种重组羧肽酶g2突变体及其基因、制备方法和应用 | |
CN111378016A (zh) | 小反刍兽疫病毒的亚单位h蛋白及其制备方法和应用 | |
WO2023109383A1 (zh) | 百日咳抗原重组表达载体及其工程菌和应用 | |
CN106939041B (zh) | 应用多克隆抗体亲和柱纯化眼镜蛇毒神经生长因子的方法 | |
CN116410266A (zh) | 一种B/Washington/02/2019(B/Victoria lineage)HA抗原制备方法 | |
CN116375806A (zh) | 一种B/Austria/1359417/2021(B/Victoria lineage)HA抗原制备方法 | |
CN117821408A (zh) | 一种重组蒿属花粉Art an7变应原蛋白及其应用 | |
CN110078815A (zh) | 一种重组人酸性成纤维细胞生长因子大规模制备方法 | |
CN116478244A (zh) | 一种A/Victoria/2570/2019(H1N1)pdm09 HA抗原制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information |
Address after: 213125 No. 518 Yunhe Road, Xinbei District, Changzhou City, Jiangsu Province Applicant after: ZonHon Biopharma Institute Inc. Applicant after: Jiangsu Jingsen Biomedical New Materials Technology Co., Ltd. Address before: 213125 No. 518 Yunhe Road, Xinbei District, Changzhou City, Jiangsu Province Applicant before: ZonHon Biopharma Institute Inc. Applicant before: Changzhou Gensun Institute of Biomedicine Co., Ltd. |
|
CB02 | Change of applicant information | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20190712 Address after: 213125 No. 518 Yunhe Road, Xinbei District, Changzhou City, Jiangsu Province Applicant after: ZonHon Biopharma Institute Inc. Address before: 213125 No. 518 Yunhe Road, Xinbei District, Changzhou City, Jiangsu Province Applicant before: ZonHon Biopharma Institute Inc. Applicant before: Jiangsu Jingsen Biomedical New Materials Technology Co., Ltd. |
|
TA01 | Transfer of patent application right | ||
GR01 | Patent grant | ||
GR01 | Patent grant |